BEAM

#1651
Beam Therapeutics Inc. Common Stock
30.08 USD
-0.73%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
29.87
30.25
Rango anual
15.35
36.44
Cambio diario
-0.73%
Variación mensual
+17.04%
Variación en los últimos 6 meses
+9.98%
Cambio anual
+77.25%
Cierres anteriores
30.30
Abrir
30.08
Bid
Ask
Mínimo
29.87
High
30.25
Volumen
1 028
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
Informe de resultados Saldo Flujo de caja
Valor Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

Beam Therapeutics Inc

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

Noticias